These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 27282852

  • 21. Utility of Urinary Biomarkers in Predicting Loss of Residual Renal Function: The balANZ Trial.
    Cho Y, Johnson DW, Vesey DA, Hawley CM, Clarke M, Topley N, balANZ Trial Investigators.
    Perit Dial Int; 2015; 35(2):159-71. PubMed ID: 24711637
    [Abstract] [Full Text] [Related]

  • 22. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
    Posthuma N, ter Wee PM, Donker AJ, Oe PL, Peers EM, Verbrugh HA.
    Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
    [Abstract] [Full Text] [Related]

  • 23. Randomized controlled study of biocompatible peritoneal dialysis solutions: effect on residual renal function.
    Fan SL, Pile T, Punzalan S, Raftery MJ, Yaqoob MM.
    Kidney Int; 2008 Jan; 73(2):200-6. PubMed ID: 17914351
    [Abstract] [Full Text] [Related]

  • 24. Impact of Obesity on Modality Longevity, Residual Kidney Function, Peritonitis, and Survival Among Incident Peritoneal Dialysis Patients.
    Obi Y, Streja E, Mehrotra R, Rivara MB, Rhee CM, Soohoo M, Gillen DL, Lau WL, Kovesdy CP, Kalantar-Zadeh K.
    Am J Kidney Dis; 2018 Jun; 71(6):802-813. PubMed ID: 29223620
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Biocompatible peritoneal dialysis solution preserves residual renal function.
    Kim S, Oh KH, Oh J, Kim SJ, Chung W, Song YR, Na KY, Oh YK, Ahn C, Kim SG, Tan KC.
    Am J Nephrol; 2012 Jun; 36(4):305-16. PubMed ID: 23007025
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effect of neutral pH and low-glucose degradation product-containing peritoneal dialysis solution on residual renal function in peritoneal dialysis patients: a meta-analysis.
    Wang J, Zhu N, Yuan W.
    Nephron; 2015 Jun; 129(3):155-63. PubMed ID: 25765060
    [Abstract] [Full Text] [Related]

  • 30. Improvement of peritoneal ultrafiltration with peritoneal dialysis solution buffered with bicarbonate/lactate mixture.
    Simonsen O, Sterner G, Carlsson O, Wieslander A, Rippe B.
    Perit Dial Int; 2006 Jun; 26(3):353-9. PubMed ID: 16722029
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis.
    Liao CT, Chen YM, Shiao CC, Hu FC, Huang JW, Kao TW, Chuang HF, Hung KY, Wu KD, Tsai TJ.
    Nephrol Dial Transplant; 2009 Sep; 24(9):2909-14. PubMed ID: 19225016
    [Abstract] [Full Text] [Related]

  • 33. Effect of biocompatible peritoneal dialysis solution on residual renal function: a systematic review of randomized controlled trials.
    Seo EY, An SH, Cho JH, Suh HS, Park SH, Gwak H, Kim YL, Ha H.
    Perit Dial Int; 2014 Sep; 34(7):724-31. PubMed ID: 25185015
    [Abstract] [Full Text] [Related]

  • 34. Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study.
    Kim S, Oh J, Kim S, Chung W, Ahn C, Kim SG, Oh KH.
    Nephrol Dial Transplant; 2009 Sep; 24(9):2899-908. PubMed ID: 19258384
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effect of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions on Residual Renal Function, Urine Volume, and Ultrafiltration: A Systematic Review and Meta-Analysis.
    Yohanna S, Alkatheeri AM, Brimble SK, McCormick B, Iansavitchous A, Blake PG, Jain AK.
    Clin J Am Soc Nephrol; 2015 Aug 07; 10(8):1380-8. PubMed ID: 26048890
    [Abstract] [Full Text] [Related]

  • 37. What is the role of automated peritoneal dialysis and continuous flow peritoneal dialysis?
    Diaz-Buxo JA.
    Contrib Nephrol; 2003 Aug 07; (140):264-71. PubMed ID: 12800368
    [No Abstract] [Full Text] [Related]

  • 38. Icodextrin Versus Glucose Solutions for the Once-Daily Long Dwell in Peritoneal Dialysis: An Enriched Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Goossen K, Becker M, Marshall MR, Bühn S, Breuing J, Firanek CA, Hess S, Nariai H, Sloand JA, Yao Q, Chang TI, Chen J, Paniagua R, Takatori Y, Wada J, Pieper D.
    Am J Kidney Dis; 2020 Jun 07; 75(6):830-846. PubMed ID: 32033860
    [Abstract] [Full Text] [Related]

  • 39. Benefits of a continuous ambulatory peritoneal dialysis (CAPD) technique with one icodextrin-containing and two biocompatible glucose-containing dialysates for preservation of residual renal function and biocompatibility in incident CAPD patients.
    Yoon HE, Chang YK, Shin SJ, Choi BS, Kim BS, Park CW, Song HC, Yoon SA, Jin DC, Kim YS.
    J Korean Med Sci; 2014 Sep 07; 29(9):1217-25. PubMed ID: 25246739
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.